Published in J Biomed Mater Res A on January 11, 2016
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature (2004) 12.75
Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov (2009) 12.46
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature (2010) 10.09
Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm (2008) 7.67
In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials (2003) 4.26
Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release (2006) 3.85
Delivery materials for siRNA therapeutics. Nat Mater (2013) 3.70
The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm (2009) 3.49
Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci U S A (1996) 2.65
Development of a novel endosomolytic diblock copolymer for siRNA delivery. J Control Release (2008) 2.32
PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur J Cell Biol (2004) 2.32
siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev (2009) 2.21
Current progress of siRNA/shRNA therapeutics in clinical trials. Biotechnol J (2011) 2.17
Delivery of siRNA therapeutics: barriers and carriers. AAPS J (2010) 2.15
The silent treatment: siRNAs as small molecule drugs. Gene Ther (2006) 2.12
Cationic polymer based gene delivery systems. Pharm Res (2000) 1.98
Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules (2009) 1.80
Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane. Proc Natl Acad Sci U S A (2012) 1.52
Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing. Biotechnol Bioeng (2007) 1.36
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials (2013) 1.34
Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials (2009) 1.34
Charge-reversal amphiphiles for gene delivery. J Am Chem Soc (2004) 1.21
Polymer brush-stabilized polyplex for a siRNA carrier with long circulatory half-life. J Control Release (2007) 1.11
Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo. ACS Nano (2013) 1.11
Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. J Vis Exp (2013) 1.08
FRET-labeled siRNA probes for tracking assembly and disassembly of siRNA nanocomplexes. ACS Nano (2012) 1.03
Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA. Proc Natl Acad Sci U S A (2014) 0.99
Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials (2009) 0.98
Polymer side-chain degradation as a tool to control the destabilization of polyplexes. Pharm Res (2004) 0.98
In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier. Biomaterials (2012) 0.95
The role of PEG architecture and molecular weight in the gene transfection performance of PEGylated poly(dimethylaminoethyl methacrylate) based cationic polymers. Biomaterials (2010) 0.92
Actively-targeted polyion complex micelles stabilized by cholesterol and disulfide cross-linking for systemic delivery of siRNA to solid tumors. Biomaterials (2014) 0.91
Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers. Biomaterials (2014) 0.90
An influenza virus-inspired polymer system for the timed release of siRNA. Nat Commun (2013) 0.88
Matrix Metalloproteinase Responsive, Proximity-activated Polymeric Nanoparticles for siRNA Delivery. Adv Funct Mater (2013) 0.87
Dual MMP7-proximity-activated and folate receptor-targeted nanoparticles for siRNA delivery. Biomacromolecules (2014) 0.87
Association and dissociation characteristics of polymer/DNA complexes used for gene delivery. Pharm Res (1999) 0.82
Light-mediated activation of siRNA Release in diblock copolymer assemblies for controlled gene silencing. Adv Healthc Mater (2014) 0.80
Self-catalyzed degradable cationic polymer for release of DNA. Biomacromolecules (2011) 0.79
Self-catalyzed degradation of linear cationic poly(2-dimethylaminoethyl acrylate) in water. Biomacromolecules (2011) 0.79
Polymer nanocarrier system for endosome escape and timed release of siRNA with complete gene silencing and cell death in cancer cells. Biomacromolecules (2013) 0.79
Targeted decationized polyplexes for siRNA delivery. Mol Pharm (2014) 0.78
Timed-release polymer nanoparticles. Biomacromolecules (2013) 0.75